project id: TCGA-BRCA; case submitter id: TCGA-AN-A04D; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 9.0; spectrophotometer method: UV Spec; age at index: 58; days to birth: -21426; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 21426; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 52.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 676; initial weight: 260.0; sample id: cbf66244-42c8-4df6-aca7-932e77bb5e0e; sample submitter id: TCGA-AN-A04D-01A; portion id: 2bc0461e-57fc-4772-80ed-6a6e6400a13f; portion submitter id: TCGA-AN-A04D-01A-21; percent lymphocyte infiltration: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0;